
The acceleration timeline (fiscal 2029 instead of 2031, per the prior context) now collides with production ramp constraints: General Atomics' current MQ-9A line is cold, and standing up an entirely new production cell for a $10M airframe leaves no margin for design iteration or test failure. If the Air Force insists on FY29 fielding with a fully missionized platform, something breaks—schedule, cost, or performance spec. The real risk is that Niemi's $10M number becomes a political anchor that locks the program into an unsustainable production rate before the design is mature, replicating the RQ-180 and MQ-4C cost-growth cycles in reverse.
The $10M airframe target forces a brutal trade-off between attrition tolerance and payload: an MMA at that price point must shed sensors, weapons integration, and redundancy to hit the number.
Niemi's explicit rejection of the MQ-9B—a more capable evolution of the Reaper—because it costs even more reveals the real constraint: the Air Force is designing for loss rate, not performance. If the service is willing to absorb higher attrition to reduce unit cost, it's betting that fleet depth (more airframes) matters more than individual platform survivability in the Iran theater—a calculation that inverts the Reaper's 20-year doctrine of precision and persistence. Watch the FY28 budget cycle for MMA production quantities; if the Air Force requests 200+ units annually instead of the typical 50–80 for a flagship ISR platform, the acceleration isn't about capability—it's about accepting expendability.
Does the $10M target include the Inertial Navigation System and Link 16 terminal, or are those in the "missionization" cost that sits outside the stated price? The difference between $10M and $15M per airframe cascades through the entire sustainment budget.
Strategic intelligence, synthesized daily — with a public track record. Every call graded against what actually happened.